Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Treeline Biosciences, Inc.

Treeline Biosciences, Inc.

Stage unknownWatertown, MAtreeline.bioBiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Aug 21, 2025
    Form D equity offering · $200M (form d sold) · 22 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Treeline Biosciences, Inc. filed Form D: $200,099,964 sold of $249,999,967, Biotechnology”
  2. Oct 2, 2024
    Form D equity offering · $422M (form d sold) · 43 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Treeline Biosciences, Inc. filed Form D: $421,779,808 sold of $421,779,808, Biotechnology”
Investors on record
1 edges
People
2 officers, 7 directors
Timeline
2
  1. Sep 4, 2025
    Treeline Biosciences, Inc. filed Form D: $200,099,964 sold of $249,999,967, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Oct 17, 2024
    Treeline Biosciences, Inc. filed Form D: $421,779,808 sold of $421,779,808, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
32 observations
Every observation on this company